New research reveals that patients who stop using popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight far faster than those who halt traditional lifestyle plans.
Findings released in a leading health publication shows that while obese individuals can lose substantial amounts of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"People using such treatments need to be cognizant of the risk of rapid rebound weight gain when the medication ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original weight within about one and a half years.
Comparing Therapies
The analysis, which examined 37 of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists emphasize that individuals who lose weight through lifestyle changes alone typically see a less rapid creep back—perhaps 100 grams monthly—after stopping.
Understanding the Quick Regain
Experts suggest the mechanism of the jabs explains the accelerated weight return.
GLP-1 drugs mimic a natural hormone called GLP-1, which controls hunger.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the system to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication means appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Issue?
The NHS advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, due to the significant potential of weight regain, the therapy is often life-long.
This opinion is supported by pharmaceutical companies, who note that the findings "emphasize the persistent character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
People who have come off the medication report a sudden resurgence of cravings.
"It felt as if a switch activating and you're instantly extremely hungry," said an individual.
This difficulty is worsened if users have not established sustainable dietary or behavioural changes during treatment.
Growing Use
Survey data indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, experts caution that while GLP-1 drugs are potent tools for shedding pounds, they are not a standalone fix and lasting health benefits relies on ongoing lifestyle management.
